% Expired Patents = 60.0

Forward Citations = 64

Loading Chart...

24 inventors (with patents filed for the assignee):

Atsushi Naganawa (1 out of 16 patents)

Kensuke Kusumi (1 out of 13 patents)

Kousuke Tani (1 out of 33 patents)

4. Takao Yoshida (1 out of 13 patents)

5. Toru Maruyama (1 out of 21 patents)

6. Kazuhiro Otsuki (1 out of 6 patents)

7. Tetsuya Sekiguchi (1 out of 10 patents)

8. Akito Kakuuchi (1 out of 8 patents)

9. Koji Shinozaki (1 out of 6 patents)

10. Shigeyuki Nonaka (1 out of 6 patents)

11. Takahiro Nekado (1 out of 3 patents)

12. Hideomi Kijima (1 out of 3 patents)

13. Shizuka Ono (1 out of 3 patents)

14. Toshihiko Nishiyama (1 out of 2 patents)

15. Shiro Shibayama (1 out of 52 patents)

5 patents: Sort by Forward Citations

1. 10836747 - Ethane-sulfonate salt of quinoline derivative (2020-11-17),

2. 10835520 - Phenyl derivative (2020-11-17),

3. 7858746 - Substance that specifically recognizes PD-1 (2010-12-28),

4. 7858650 - Medicinal composition for inhalation (2010-12-28),

5. 7858610 - [object Object] (2010-12-28),

Company Overview

Ono Pharmaceutical Co., Ltd. is a leading Japanese pharmaceutical company focused on the research, development, manufacturing, and marketing of innovative drugs. Established in 1717, Ono has a rich history and is dedicated to addressing unmet medical needs through its advanced research in areas such as oncology, immunology, and central nervous system disorders. The company is known for its commitment to high-quality standards and has a strong pipeline of products aimed at improving patient outcomes globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#717 in Osaka

#6,652 in Japan

Osaka, Japan

Ono Pharmaceuticalco.,ltd.

Forward Citations = 64

24 inventors:

Atsushi Naganawa (1 out of 16 patents)

Kensuke Kusumi (1 out of 13 patents)

Kousuke Tani (1 out of 33 patents)

4. Takao Yoshida (1 out of 13 patents)

5. Toru Maruyama (1 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ono Pharmaceuticalco.,ltd.. Retrieved from https://idiyas.com/company/ono-pharmaceuticalco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]